BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 10192099)

  • 1. In vitro effect of Cl2Ca and Cl2Mg on warfarin-human serum albumin (HSA) binding.
    Pérez Gallardo L
    Magnes Res; 1999 Mar; 12(1):43-8. PubMed ID: 10192099
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Interaction of warfarin with human serum albumin. A stoichiometric description.
    Larsen FG; Larsen CG; Jakobsen P; Brodersen R
    Mol Pharmacol; 1985 Feb; 27(2):263-70. PubMed ID: 3969070
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Investigations of the effects of ethanol on warfarin binding to human serum albumin.
    Ha CE; Petersen CE; Park DS; Harohalli K; Bhagavan NV
    J Biomed Sci; 2000; 7(2):114-21. PubMed ID: 10754385
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The HSA affinity of warfarin and flurbiprofen determined by fluorescence anisotropy measurements of camptothecin.
    Wybranowski T; Cyrankiewicz M; Ziomkowska B; Kruszewski S
    Biosystems; 2008 Dec; 94(3):258-62. PubMed ID: 18721856
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Spectroscopic techniques in the study of protein binding. A fluorescence technique for the evaluation of the albumin binding and displacement of warfarin and warfarin-alcohol.
    Sudlow G; Birkett DJ; Wade DN
    Clin Exp Pharmacol Physiol; 1975; 2(2):129-40. PubMed ID: 1139797
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Binding of warfarin by human albumin in the presence of a perfluorochemical blood substitute.
    Parsons DL; Ravis WR; Clark CR
    Arch Int Pharmacodyn Ther; 1985 Sep; 277(1):4-14. PubMed ID: 4062432
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Characterization of thyroxine-albumin binding using high-performance affinity chromatography. I. Interactions at the warfarin and indole sites of albumin.
    Loun B; Hage DS
    J Chromatogr; 1992 Sep; 579(2):225-35. PubMed ID: 1429970
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Using difference spectrophotometry to study the influence of different ions and buffer systems on drug protein binding.
    Afifi NN
    Drug Dev Ind Pharm; 1999 Jun; 25(6):735-43. PubMed ID: 10349559
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Competition between serum albumin and soluble fraction of liver for binding of warfarin and other drugs.
    Wosilait WD; Ryan MP; Byington KH
    Res Commun Chem Pathol Pharmacol; 1981 Apr; 32(1):113-21. PubMed ID: 7291718
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of ibuprofen and warfarin on the allosteric properties of haem-human serum albumin. A spectroscopic study.
    Baroni S; Mattu M; Vannini A; Cipollone R; Aime S; Ascenzi P; Fasano M
    Eur J Biochem; 2001 Dec; 268(23):6214-20. PubMed ID: 11733017
    [TBL] [Abstract][Full Text] [Related]  

  • 11. High-resolution and high-throughput protocols for measuring drug/human serum albumin interactions using BIACORE.
    Rich RL; Day YS; Morton TA; Myszka DG
    Anal Biochem; 2001 Sep; 296(2):197-207. PubMed ID: 11554715
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Binding of urapidil to human serum albumin: dependency on free fatty acid concentration.
    Storck J; Kirsten R
    Int J Clin Pharmacol Ther Toxicol; 1991 May; 29(5):204-8. PubMed ID: 2071271
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Rodenticidal action of warfarin/4th communication: Binding to serum albumin of mice and rats (author's transl)].
    von Oettingen U; Niedner R; Meyer F
    Arzneimittelforschung; 1975 Nov; 25(11):1705-6. PubMed ID: 1243077
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pharmaceutical-grade albumin: impaired drug-binding capacity in vitro.
    Olsen H; Andersen A; Nordbø A; Kongsgaard UE; Børmer OP
    BMC Clin Pharmacol; 2004 Mar; 4():4. PubMed ID: 15046641
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Stereoselective kinetics of warfarin binding to human serum albumin: effect of an allosteric interaction.
    Fitos I; Visy J; Kardos J
    Chirality; 2002 May; 14(5):442-8. PubMed ID: 11984760
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Identification of two bromocresol purple binding sites on human serum albumin.
    Ito S; Yamamoto D
    Clin Chim Acta; 2010 Oct; 411(19-20):1536-8. PubMed ID: 20570667
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Plasma protein binding of metbufen, a new non-steroid anti-inflammatory drug, in humans.
    Brunner F; Zini R; Tillement JP
    Int J Clin Pharmacol Ther Toxicol; 1984 Mar; 22(3):134-9. PubMed ID: 6201451
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Consequences of the N-B transition of albumin for the binding of warfarin in human serum.
    van der Giesen WF; Wilting J
    Biochem Pharmacol; 1983 Jan; 32(2):281-5. PubMed ID: 6870956
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The effects of pH, calcium and chloride ions on the binding of tolmetin to human serum albumin: circular dichroic, dialysis and fluorometric measurements.
    Matsuyama K; Sen AC; Perrin JH
    J Pharm Pharmacol; 1987 Mar; 39(3):190-5. PubMed ID: 2883283
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Development of tryptophan-modified human serum albumin columns for site-specific studies of drug-protein interactions by high-performance affinity chromatography.
    Chattopadhyay A; Tian T; Kortum L; Hage DS
    J Chromatogr B Biomed Sci Appl; 1998 Sep; 715(1):183-90. PubMed ID: 9792509
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.